尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Shah Rajeev M., 董事. Insider active across 3 companies, notably Black Diamond Therapeutics, Inc.. Aggregated, 3 reports have been recorded. Activity tracked since 20 May 2021. The latest transaction was filed on 6 June 2023 (U). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Shah Rajeev M. is a Board Member at Black Diamond Therapeutics, Inc. and Kala Pharmaceuticals, Inc. He contributes to the governance of these companies by participating in strategic decision-making and overseeing operations. His experience in the pharmaceutical sector is an asset for the organizations.